Impact of Prophylactic Low-molecular Weight Heparin Dosing on Clotting Parameters Following Cesarean Delivery
Status:
Recruiting
Trial end date:
2023-03-15
Target enrollment:
Participant gender:
Summary
The aim of this study is to evaluate the efficacy of two dosing regimens of low molecular
weight heparin (LMWH) to reach prophylactic anti-factor Xa levels in post-cesarean delivery
women. Half of participants will receive a fixed dose of LMWH, while the other half will
receive a weight-based dose. The hypothesis is that the use of a weight-based dose will
result in more women reaching prophylactic levels.